91 related articles for article (PubMed ID: 12115660)
1. T helper differentiation in resistant and susceptible B7-deficient mice infected with Leishmania major.
Brown JA; Greenwald RJ; Scott S; Schweitzer AN; Satoskar AR; Chung C; Schopf LR; van der Woude D; Sypek JP; Sharpe AH
Eur J Immunol; 2002 Jun; 32(6):1764-72. PubMed ID: 12115660
[TBL] [Abstract][Full Text] [Related]
2. Expression and contribution of B7-1 (CD80) and B7-2 (CD86) in the early immune response to Leishmania major infection.
Elloso MM; Scott P
J Immunol; 1999 Jun; 162(11):6708-15. PubMed ID: 10352289
[TBL] [Abstract][Full Text] [Related]
3. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.
Bian Y; Hiraoka S; Tomura M; Zhou XY; Yashiro-Ohtani Y; Mori Y; Shimizu J; Ono S; Dunussi-Joannopoulos K; Wolf S; Fujiwara H
Int Immunol; 2005 Jan; 17(1):73-83. PubMed ID: 15569772
[TBL] [Abstract][Full Text] [Related]
4. Effects of blocking B7-1 and B7-2 interactions during a type 2 in vivo immune response.
Greenwald RJ; Lu P; Halvorson MJ; Zhou X; Chen S; Madden KB; Perrin PJ; Morris SC; Finkelman FD; Peach R; Linsley PS; Urban JF; Gause WC
J Immunol; 1997 May; 158(9):4088-96. PubMed ID: 9126967
[TBL] [Abstract][Full Text] [Related]
5. Newcastle disease virus infection induces B7-1/B7-2-independent T-cell costimulatory activity in human melanoma cells.
Termeer CC; Schirrmacher V; Bröcker EB; Becker JC
Cancer Gene Ther; 2000 Feb; 7(2):316-23. PubMed ID: 10770642
[TBL] [Abstract][Full Text] [Related]
6. Blockade of CD86 in BALB/c mice infected with Leishmania major does not prevent the expansion of low avidity T cells.
Moro M; Filippi C; Gallard A; Malherbe L; Foucras G; Akiba H; Yagita H; Guéry JC; Glaichenhaus N
Eur J Immunol; 2002 Dec; 32(12):3566-75. PubMed ID: 12516542
[TBL] [Abstract][Full Text] [Related]
7. T-cell responses to immunodominant LACK antigen do not play a critical role in determining susceptibility of BALB/c mice to Leishmania mexicana.
Torrentera FA; Glaichenhaus N; Laman JD; Carlier Y
Infect Immun; 2001 Jan; 69(1):617-21. PubMed ID: 11119565
[TBL] [Abstract][Full Text] [Related]
8. Importance of the B7-2 molecule for low dose melphalan-induced acquisition of tumor-eradicating immunity by mice bearing a large MOPC-315 tumor.
Mokyr MB; Kalinichenko TV; Gorelik L; Bluestone JA
J Immunol; 1998 Feb; 160(4):1866-74. PubMed ID: 9469448
[TBL] [Abstract][Full Text] [Related]
9. Macrophage-T cell interaction in experimental visceral leishmaniasis: failure to express costimulatory molecules on Leishmania-infected macrophages and its implication in the suppression of cell-mediated immunity.
Saha B; Das G; Vohra H; Ganguly NK; Mishra GC
Eur J Immunol; 1995 Sep; 25(9):2492-8. PubMed ID: 7589116
[TBL] [Abstract][Full Text] [Related]
10. B7-1/B7-2 costimulation regulates plaque antigen-specific T-cell responses and atherogenesis in low-density lipoprotein receptor-deficient mice.
Buono C; Pang H; Uchida Y; Libby P; Sharpe AH; Lichtman AH
Circulation; 2004 Apr; 109(16):2009-15. PubMed ID: 15096453
[TBL] [Abstract][Full Text] [Related]
11. LACK-reactive CD4+ T cells require autocrine IL-2 to mediate susceptibility to Leishmania major.
Gumy A; Aseffa A; Rachinel N; Breton M; Otten L; Tacchini-Cottier F; Röcken M; Doyen N; Acha-Orbea H; Locksley RM; MacDonald HR; Launois P; Louis J
Eur J Immunol; 2006 Jun; 36(6):1465-73. PubMed ID: 16637008
[TBL] [Abstract][Full Text] [Related]
12. The involvement of neutrophils in the resistance to Leishmania major infection in susceptible but not in resistant mice.
Chen L; Zhang ZH; Watanabe T; Yamashita T; Kobayakawa T; Kaneko A; Fujiwara H; Sendo F
Parasitol Int; 2005 Jun; 54(2):109-18. PubMed ID: 15866472
[TBL] [Abstract][Full Text] [Related]
13. Further characterization of UVB radiation effects on Langerhans cells: altered expression of the costimulatory molecules B7-1 and B7-2.
Denfeld RW; Tesmann JP; Dittmar H; Weiss JM; Schöpf E; Weltzien HU; Simon JC
Photochem Photobiol; 1998 May; 67(5):554-60. PubMed ID: 9613238
[TBL] [Abstract][Full Text] [Related]
14. B7-2 is required for the progression but not the initiation of the type 2 immune response to a gastrointestinal nematode parasite.
Greenwald RJ; Urban JF; Ekkens MJ; Chen S; Nguyen D; Fang H; Finkelman FD; Sharpe AH; Gause WC
J Immunol; 1999 Apr; 162(7):4133-9. PubMed ID: 10201938
[TBL] [Abstract][Full Text] [Related]
15. Splenectomy does not interfere with immune response to Leishmania major infection in mice.
Maioli TU; Carneiro CM; Assis FA; Faria AM
Cell Immunol; 2007 Sep; 249(1):1-7. PubMed ID: 18093575
[TBL] [Abstract][Full Text] [Related]
16. Mast cell degranulation contributes to susceptibility to Leishmania major.
Romão PR; Da Costa Santiago H; Ramos CD; De Oliveira CF; Monteiro MC; De Queiroz Cunha F; Vieira LQ
Parasite Immunol; 2009 Mar; 31(3):140-6. PubMed ID: 19222785
[TBL] [Abstract][Full Text] [Related]
17. Dissociation of disease susceptibility, inflammation and cytokine profile in lmr1/2 congenic mice infected with Leishmania major.
Elso C; Kumar B; Smyth G; Foote S; Handman E
Genes Immun; 2004 May; 5(3):188-96. PubMed ID: 14762398
[TBL] [Abstract][Full Text] [Related]
18. Host genetic background determines whether IL-18 deficiency results in increased susceptibility or resistance to murine Leishmania major infection.
Wei XQ; Niedbala W; Xu D; Luo ZX; Pollock KG; Brewer JM
Immunol Lett; 2004 Jun; 94(1-2):35-7. PubMed ID: 15234532
[TBL] [Abstract][Full Text] [Related]
19. B7.2-Ig fusion proteins enhance IL-4-dependent differentiation of tumor-sensitized CD8+ cytotoxic T lymphocyte precursors.
Hiraoka S; Takeuchi N; Bian Y; Nakahara H; Kogo M; Dunussi-Joannopoulos K; Wolf S; Ono S; Fujiwara H
Int Immunol; 2005 Aug; 17(8):1071-9. PubMed ID: 16027141
[TBL] [Abstract][Full Text] [Related]
20. Blockade of CD86 ameliorates Leishmania major infection by down-regulating the Th2 response.
Brown JA; Titus RG; Nabavi N; Glimcher LH
J Infect Dis; 1996 Dec; 174(6):1303-8. PubMed ID: 8940222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
